**Allison Wey, Senior Vice President of Investor Relations & Corporate Communications**
Thank you, Sami. Good morning, and welcome, everyone, to the Xeris Biopharma Third Quarter 2025 Earnings Call.
You can find this morning’s earnings release and our detailed financial results on the Investor Relations section of our website.
Today, I’m joined by John Shannon, CEO; and Steve Pieper, our CFO. After our prepared remarks, we will open the line for questions.
Before we begin, I’d like to remind you that this call will contain certain forward-looking statements concerning the company’s future expectations, plans, projects, and financial performance. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those forward-looking statements.
For more information on our risks, please refer to our earnings release and risk factors included in our SEC filings. Any forward-looking statements in this call represent our views only as of the date of this call.
https://seekingalpha.com/article/4839301-xeris-biopharma-holdings-inc-xers-q3-2025-earnings-call-transcript?source=feed_all_articles